Skip to main content

Attrition Rates for M.D.-Ph.D. Programs Vary by Race, Ethnicity

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Aug. 1, 2023 -- There are significant racial and ethnic disparities in rates of attrition from M.D.-Ph.D. training programs, according to a research letter published online July 31 in JAMA Internal Medicine.

Mytien Nguyen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined how attrition rates among M.D.-Ph.D. matriculants differ by race and ethnicity. The analysis included Association of American Medical data on 4,702 M.D.-Ph.D. matriculants (2004 to 2012).

The researchers found that 83.6 percent of matriculants completed M.D.-Ph.D. training, 12.3 percent graduated with their M.D. only, and 4.1 percent left medical school. Compared with other M.D.-Ph.D. matriculants of other race/ethnicity groups, graduating with an M.D. only was more common for Black students (20.0 percent) compared with White (12.4 percent), Asian (11.4 percent), Hispanic (13.2 percent), and multiracial (9.8 percent) matriculants. Additionally, more Black M.D.-Ph.D. matriculants left medical school (8.4 percent) than White matriculants (4.3 percent). The odds of graduating with only an M.D. and leaving medical school were higher for Black than for White students (adjusted odds ratios, 1.50 and 1.83, respectively), after adjusting for Medical College Admission Test quartile.

"The disparity in attrition for Black M.D.-Ph.D. students could have implications for the racial diversity of the biomedical workforce," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.